A method for treating a subject suffering from age related illnesses such as Type 2 diabetes by administering to the subject a compound to down regulate Factor D or Factor H thereby providing prophylaxis and therapy to inhibit age related illnesses. The compound is a functionalized Nano Polymer of less than 100 nm, which primarily inhibits Factor D, Factor H, or both.